苦参素胶囊联合氯雷他定治疗慢性荨麻疹的临床观察

目的:观察苦参素治疗慢性荨麻疹的临床疗效。方法:80例慢性荨麻疹患者随机分为治疗组和对照组各40例,治疗组用苦参素联合氯雷他定治疗;对照组仅口服氯雷他定片治疗。比较两组患者临床疗效。结果:治疗组的总有效率为82.5%,对照组为60.0%(P<0.05);治疗结束1个月后随访,治疗组复发率为20.0%,对照组为65.0%(P<0.05)。结论:苦参素治疗慢性荨麻疹疗效确切。

Objective：To observe the clinical of Marine capsules therapy in the treatment of chronic urtic.,aria.Methods：80 Cases chronic urticaria patients were randomly divied into treatment group and control group, the treatment group was treated with compound Marine capsules and the Loratadine tablets, the control group was treated with Loratadine tablets.Results： The effective rate was 82.5% in the treatment group and 60.0% in the control group,The response rate of Marine capsules therapy combined the Loratadine tablets groups was significantly higher than the Loratadine tablets groups （P〈0.05） .Conclusion：Marine capsules therapy is a safe and effective choice for chronic urticaria patient.